Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Source Tissue

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)

Search term: breast cancer cell

Results 1 - 100 of 309 > >>
download as CSV
download all results as CSV
EC Number Recommended Name Source Tissue Commentary Reference
Display the reaction diagram Show all sequences 3.2.1.1271,6-alpha-L-fucosidase breast cancer cell - 699825
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B461-acylglycerophosphatidylinositol O-acyltransferase breast cancer cell - 757632
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.671-phosphatidylinositol 4-kinase breast cancer cell non-specific infiltrating duct and infiltrating lobular carcinomas 721967
Show all pathways known for 1.1.1.141Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.14115-hydroxyprostaglandin dehydrogenase (NAD+) breast cancer cell - 700197
Show all pathways known for 1.1.1.141Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.14115-hydroxyprostaglandin dehydrogenase (NAD+) breast cancer cell expression of the enzyme and the estrogen receptor is correlated 668162
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase breast cancer cell - 685545, 711649, 713021, 726302, 740542, 740839, 740849, 761756, 761900
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase breast cancer cell 17beta-HSD1 is overexpressed in many breast tumors 688272
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase breast cancer cell the inhibition of the enzyme (17beta-HSD7) constitutes the basis of breast cancer cell proliferation 761756
Show all pathways known for 1.1.1.51Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.513(or 17)beta-hydroxysteroid dehydrogenase breast cancer cell - 761900
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.3573alpha-hydroxysteroid 3-dehydrogenase breast cancer cell - 740017
Show all pathways known for 1.1.1.213Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2133alpha-hydroxysteroid 3-dehydrogenase (Re-specific) breast cancer cell - 675678
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.503alpha-hydroxysteroid 3-dehydrogenase (Si-specific) breast cancer cell - 740017
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase breast cancer cell - 656788, 763397
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase breast cancer cell 3beta-hydroxysteroid dehydrogenase type 1 693887
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase breast cancer cell isozyme 3beta-HSD1 662371
Show all pathways known for 1.1.1.270Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2703beta-hydroxysteroid 3-dehydrogenase breast cancer cell 17beta-HSD7 is amplified in primary and progressive breast cancer 763396
Show all pathways known for 1.1.1.270Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2703beta-hydroxysteroid 3-dehydrogenase breast cancer cell 3beta-HSD1 is selectively expressed in human placenta, mammary glands and breast tumors in women 763397
Show all pathways known for 1.1.1.270Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2703beta-hydroxysteroid 3-dehydrogenase breast cancer cell expression of 3beta-hydroxysteroid dehydrogenase type 1 (HSD3B1) in breast cancer is associated with shorter recurrence-free survival, and genetic or pharmacologic inhibition of HSD3B1 reduced colony formation and xenograft growth 763404
Show all pathways known for 1.1.1.270Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2703beta-hydroxysteroid 3-dehydrogenase breast cancer cell selective expression of 3beta-HSD1 725813
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.1524-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase breast cancer cell - 735901
Display the word mapDisplay the reaction diagram Show all sequences 3.6.1.625'-(N7-methylguanosine 5'-triphospho)-[mRNA] hydrolase breast cancer cell - 758325
Show all pathways known for 3.1.3.5Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.55'-nucleotidase breast cancer cell - 682217, 691078, 693298, 750845
Show all pathways known for 3.5.2.9Display the word mapDisplay the reaction diagram Show all sequences 3.5.2.95-oxoprolinase (ATP-hydrolysing) breast cancer cell - 694485
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.1056-phosphofructo-2-kinase breast cancer cell - 737973, 760902, 761915
Display the word mapDisplay the reaction diagram Show all sequences 7.6.2.2ABC-type xenobiotic transporter breast cancer cell - 747044
Show all pathways known for 6.4.1.2Display the word mapDisplay the reaction diagram Show all sequences 6.4.1.2acetyl-CoA carboxylase breast cancer cell - 672908, 675919
Show all pathways known for 3.1.3.2Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.2acid phosphatase breast cancer cell - 679089
Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.53acireductone dioxygenase (Ni2+-requiring) breast cancer cell - 764226
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.94acylglycerol kinase breast cancer cell enzyme overexpression 739046
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B10ADAM12 endopeptidase breast cancer cell - 670445, 719935, 754703, 754704, 755485
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B10ADAM12 endopeptidase breast cancer cell primary breast cancer cell BC1205 755485
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B10ADAM12 endopeptidase breast cancer cell primary breast cancer cell BC1302 755485
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.82ADAMTS-4 endopeptidase breast cancer cell - 754958
Show all pathways known for 3.5.4.4Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.4adenosine deaminase breast cancer cell - 718704
Show all pathways known for 3.5.4.4Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.4adenosine deaminase breast cancer cell the activity of isozyme ADA2 is increased 668272
Display the reaction diagram Show all sequences 2.7.7.96ADP-D-ribose pyrophosphorylase breast cancer cell - 761999, 762060
Show all pathways known for 1.2.1.3Display the word mapDisplay the reaction diagram Show all sequences 1.2.1.3aldehyde dehydrogenase (NAD+) breast cancer cell - 697114
Display the word mapDisplay the reaction diagram Show all sequences 3.1.4.39alkylglycerophosphoethanolamine phosphodiesterase breast cancer cell - 696397, 703104, 728853
Display the word mapDisplay the reaction diagram Show all sequences 3.1.4.39alkylglycerophosphoethanolamine phosphodiesterase breast cancer cell overexpression of the enzyme is frequently observed in cancer tissues, such as breast cancer and glioblastoma 728853
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.155alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase breast cancer cell - 693867
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.155alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase breast cancer cell epithelial and metastatic 758997
Show all pathways known for 3.2.1.51Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.51alpha-L-fucosidase breast cancer cell - 699825
Show all pathways known for 5.1.99.4Display the word mapDisplay the reaction diagram Show all sequences 5.1.99.4alpha-methylacyl-CoA racemase breast cancer cell - 681814, 727322
Display the reaction diagram Show all sequences 2.4.3.8alpha-N-acetylneuraminate alpha-2,8-sialyltransferase breast cancer cell - 736910
Display the reaction diagram Show all sequences 2.4.3.8alpha-N-acetylneuraminate alpha-2,8-sialyltransferase breast cancer cell tissue samples of primary invasive breast cancer cases 699089
Show all pathways known for 1.13.11.33Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.33arachidonate 15-lipoxygenase breast cancer cell - 676925
Display the word mapDisplay the reaction diagram Show all sequences 6.2.1.15arachidonate-CoA ligase breast cancer cell a breast cancer cell model, comprising different cell lines, expresses ACSL4 in all cell lines, high expression level 716687
Show all pathways known for 4.3.2.1Display the word mapDisplay the reaction diagram Show all sequences 4.3.2.1argininosuccinate lyase breast cancer cell the enzynme is overexpressed in breast cancer 748794
Show all pathways known for 4.1.1.28Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.28aromatic-L-amino-acid decarboxylase breast cancer cell different splicing variants 748845
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.5arylamine N-acetyltransferase breast cancer cell - 735771, 735849, 756146
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.5arylamine N-acetyltransferase breast cancer cell methylation status and the transcriptional activity of NAT1 in breast cancer tissues: methylation of NAT1 gene is identified in 39 of the breast carcinomas (54.2%), 23 normal (76.7%) and 25 benign breast tissue samples (80.6%). Breast cancer tissues show significantly lower methylation rates of the NAT1 promoters than the normal and benign tissues. Cancer tissues show lower methylation density rates than normal and benign breast tissues. Tissues that show aberrant methylation of NAT1 show significantly less mRNA expression compared with the unmethylated cases. 20 cancers from the methylated group show positive staining for the estrogen receptor (ER) (51.3%), while 72.7% from the unmethylated group stain positive 689296
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.5arylamine N-acetyltransferase breast cancer cell NAT1 is overexpressed in estrogen receptor-positive breast cancer 686256
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.5arylamine N-acetyltransferase breast cancer cell patients with ductal carcinoma 676155
Display the word mapDisplay the reaction diagram Show all sequences 3.1.6.1arylsulfatase (type I) breast cancer cell enzyme expression is unaltered in cancer tissue compared to nonmalignant tissue 707966
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.102beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase breast cancer cell - 759882
Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.12biotinidase breast cancer cell analysis of gene expression in breast cancer plasma, diverse tissue samples, profiling, overview 711589
Show all pathways known for 2.6.1.42Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.42branched-chain-amino-acid transaminase breast cancer cell - 758728
Show all pathways known for 2.6.1.42Display the word mapDisplay the reaction diagram Show all sequences 2.6.1.42branched-chain-amino-acid transaminase breast cancer cell BCATc and BCATm are increased in breast cancer 758657
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.17Ca2+/calmodulin-dependent protein kinase breast cancer cell - 664865
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.17Ca2+/calmodulin-dependent protein kinase breast cancer cell differential expression of CaM-KI and CaM-KII in cell lines MCF-7 and MCF-10A 664506
Show all pathways known for 1.14.15.18Display the word mapDisplay the reaction diagram Show all sequences 1.14.15.18calcidiol 1-monooxygenase breast cancer cell - 671357, 695621
Show all pathways known for 1.14.15.18Display the word mapDisplay the reaction diagram Show all sequences 1.14.15.18calcidiol 1-monooxygenase breast cancer cell the enzyme expression is reduced in breast cancer cell specimen compared to healthy breast tissue 672857
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.B29calpain 9 breast cancer cell expression analysis 731549
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.52calpain-1 breast cancer cell - 710164
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.53calpain-2 breast cancer cell - 732050
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.26cancer procoagulant breast cancer cell - 668137
Show all pathways known for 2.3.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.21carnitine O-palmitoyltransferase breast cancer cell - 757235
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.63caspase-10 breast cancer cell - 710209
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.56caspase-3 breast cancer cell - 695620, 696872, 697055
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.56caspase-3 breast cancer cell a breast cancer Dox resistant MCF-7/Dox cell line 697054
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.59caspase-6 breast cancer cell - 647467
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.59caspase-6 breast cancer cell invasive operable pT1 and pT2 ductal breast carcinoma are analysed of 210 patients: caspase-6 is overexpressed in 52.9% 680072
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.61caspase-8 breast cancer cell - 695620, 697053, 697261
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.62caspase-9 breast cancer cell - 717277, 731452
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.6catechol O-methyltransferase breast cancer cell - 658443, 702678
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.1cathepsin B breast cancer cell - 36625, 753138
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.5cathepsin D breast cancer cell - 695419, 695654, 711855, 755627
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.41cathepsin F breast cancer cell - 668085
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.38cathepsin K breast cancer cell biopsy sites, benign lesions, ductal carcinoma in situ, and invasive breast tumors of different stages. Neither epithelial nor stromal expression of CTSK is significantly associated with recurrence-free or overall survival 697375
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.15cathepsin L breast cancer cell - 752936, 755110
Display the word mapDisplay the reaction diagram Show all sequences 3.4.18.1cathepsin X breast cancer cell - 710431
Show all pathways known for 3.5.1.23Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.23ceramidase breast cancer cell - 733498
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.80ceramide glucosyltransferase breast cancer cell - 722787, 736201
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.138ceramide kinase breast cancer cell - 761664
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.138ceramide kinase breast cancer cell CERK expression is associated with an increased risk of recurrence in women with breast cancer 737976
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.138ceramide kinase breast cancer cell tissue samples of primary invasive breast cancer cases 699089
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.12cGMP-dependent protein kinase breast cancer cell - 721503, 723796
Display the word mapDisplay the reaction diagram Show all sequences 3.6.4.B10chaperonin ATPase (protein-folding, protecting from aggregation, protein stabilizing) breast cancer cell - 756668
Display the word mapDisplay the reaction diagram Show all sequences 3.3.2.11cholesterol-5,6-oxide hydrolase breast cancer cell enzyme ChEH is upregulated 752861
Show all pathways known for 2.7.1.32Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.32choline kinase breast cancer cell - 671362, 672898, 723311, 759595, 760183
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.45complement factor I breast cancer cell - 753137
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.22cyclin-dependent kinase breast cancer cell - 491470, 665497, 681873, 723656
Display the word mapDisplay the reaction diagram Show all sequences 3.4.11.3cystinyl aminopeptidase breast cancer cell N-methyl nitrosourea (NMU)-induced breast cancer 753943
Show all pathways known for 5.3.3.8Display the word mapDisplay the reaction diagram Show all sequences 5.3.3.8DELTA3-DELTA2-enoyl-CoA isomerase breast cancer cell - 691485
Show all pathways known for 2.7.1.74Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.74deoxycytidine kinase breast cancer cell - 761315
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.107diacylglycerol kinase (ATP) breast cancer cell - 761306
Show all pathways known for 2.3.1.57Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.57diamine N-acetyltransferase breast cancer cell - 756851
Show all pathways known for 2.3.1.57Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.57diamine N-acetyltransferase breast cancer cell in breast tumors, SSAT is increased contributing to an increase in acetylated polyamines 701622
Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.1dihydropyrimidine dehydrogenase (NAD+) breast cancer cell - 686604, 688302, 689367
Display the word mapDisplay the reaction diagram Show all sequences 5.6.2.1DNA topoisomerase breast cancer cell - 750368
Results 1 - 100 of 309 > >>
download as CSV
download all results as CSV